Hyperfine (HYPR)

The company’s technology is aimed at hospitals, emergency departments, intensive care units, and other care environments where rapid access to neuroimaging can be important. By using lower magnetic field strength and software-driven image processing, Hyperfine seeks to reduce some of the cost, infrastructure, and logistical barriers associated with traditional MRI. The system is positioned as a complement to existing imaging infrastructure rather than a full replacement for high-field MRI in every use case.

Hyperfine generates revenue from sales of Swoop systems and from service-related offerings, including maintenance, software, and subscription-based arrangements. Its business includes product development, manufacturing and supply, commercialization, customer support, and ongoing software enhancement for the Swoop platform.

The company operates within the health technology and medical device markets, where adoption depends on clinical utility, regulatory clearances, reimbursement dynamics, hospital budgets, and evidence showing how portable imaging can improve workflows and patient care. Hyperfine is distinctive for its focus on AI-enabled, ultra-low-field portable MRI, a niche that targets the gap between the high diagnostic value of MRI and the practical limitations of traditional scanner availability.